NCT02750202 2026-01-23
TheraVACCS
University of Pretoria
Phase 3 Completed
Clinical Trials
28 trialsNCT05087849 2025-10-02
Intralesional HPV Vaccine for Condylomata
University of California, San Francisco
Phase 1/2 Completed
NCT06915779 2025-04-08
Long Term Follow-up of HPV Vaccine in HIV (CTN 236)
University of British Columbia
Completed
NCT06700941 2024-11-22
Impact of HPV Vaccination Against Cervical Lesions and Genital Warts in Colombia. an Ecological Assessment
Universidad Nacional de Colombia
Completed
NCT06281353 2024-02-28
The Effect of Oral Nanocurcumin as an Adjuvant Therapy for Anogenital Warts: Evaluation of Clinical Improvement, NFĸB, IFN-γ, and FOXP3+TReg From Lesions Tissue
Indonesia University
Phase 2/3 Completed
NCT04782895 2023-06-15
Immunogenicity of a Recombinant Human Papillomavirus Nonavalent (Types 6,11,16,18,31,33,45,52,58)Vaccine(E.Coli) Versus Gardasil®9 in Healthy Females 18-26 Years of Age
Xiamen University
Phase 3 Completed
NCT00973856 2023-01-31
Evaluation of the Effectiveness of an Alcohol Based Hand Gel for the Reduction of Warts on the Hands
Cleveland Clinic Akron General
Phase NA Completed
NCT02405520 2022-05-24
Safety and Immunogenicity Study of the Recombinant Human Papillomavirus Virus Type 6/11 Bivalent Vaccine
Xiamen University
Phase 1 Completed
NCT03813940 2021-04-08
Safety Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli)
Xiamen University
Phase 1 Completed
NCT03935204 2021-04-08
Immunogenicity Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli)
Xiamen University
Phase 2 Completed
NCT04796090 2021-03-15
Genital Wart and Sexuality in Adolescence
Ankara City Hospital Bilkent
Completed
NCT02188004 2019-05-07
The Epidemiologic Study of Human Papillomavirus Infection and Related Diseases
Xiamen University
Completed
NCT03625960 2018-08-10
Cantharone for the Treatment of Perenial Warts
Wayne State University
Phase 4 Completed
NCT02015260 2017-05-03
A Trial of the Efficacy and Safety of Topical Nitric Oxide in Patients With Anogenital Warts
University of Aberdeen
Phase 2 Completed
NCT02558803 2016-05-25
HPV Vaccination: Evaluation of Reminder Prompts for Doses 2 & 3
Regenstrief Institute, Inc.
Phase NA Completed
NCT01520194 2016-05-10
GWburden
BEMFAM-Bem Estar Familiar
Completed
NCT02551887 2016-03-11
HPV Vaccination: An Investigation of Physician Reminders and Recommendation Scripts
Regenstrief Institute, Inc.
Phase NA Completed
NCT01598779 2015-12-21
Human Papillomavirus (HPV) Types Present in External Genital Warts (EGW) in the Argentinean Population
University of Buenos Aires
Completed
NCT01387412 2015-12-02
VIVA
University of California, Los Angeles
Completed
NCT02276521 2015-09-23
Evaluation of Long Term Immunity Following HPV Vaccination
Murdoch Childrens Research Institute
Completed
NCT00501137 2015-04-10
BCGov-01
University of British Columbia
Phase 3 Completed
NCT00862810 2014-11-20
ADS
Duke University
Phase 4 Completed
NCT02280642 2014-10-31
ADS
Duke University
Completed
NCT01676792 2014-04-22
SR-T100 Gel Efficacy & Safety Study for Vulva Pre-cancerous Lesions & Cutaneous Condyloma
National Cheng-Kung University Hospital
Phase EARLY_PHASE1 Completed
NCT01553994 2013-03-18
Effectiveness Study of Gardasil on Condyloma
Karolinska Institutet
Completed
NCT01192282 2013-01-24
Typing of Human Papilloma Virus (HPV) From Female Genital Warts
University of Cape Town
Completed
NCT00739258 2012-01-23
Surveillance and Medical Help for HIV-infected Intravenous Drug Users in and Out of Prison
Kaohsiung Medical University Chung-Ho Memorial Hospital
Completed
NCT00999986 2009-11-25
Low Dose Cyclophosphamide Treats Genital Warts
Huazhong University of Science and Technology
Phase 3 Completed